Immunocore Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	467.71	455.73	442.63	402.47	322.11
Short-Term Investments	396.44	364.65	-	-	-
Cash & Short-Term Investments	864.15	820.38	442.63	402.47	322.11
Cash Growth	5.34%	85.34%	9.98%	24.95%	81.88%
Accounts Receivable	73.98	63.01	52.09	33.58	8.19
Other Receivables	27.14	20.09	9.34	23.5	15.03
Receivables	101.12	83.1	61.44	57.08	23.22
Inventory	6.74	5.45	4.5	0.69	-
Prepaid Expenses	17.98	13.05	10.55	10.11	10.41
Other Current Assets	6.75	7.9	9.71	3.62	-
Total Current Assets	996.74	929.86	528.82	473.98	355.75
Property, Plant & Equipment	50.25	47.74	42.74	38.78	42.7
Long-Term Deferred Tax Assets	-	14.79	10.97	5.12	3.49
Other Long-Term Assets	20.28	17.12	14.47	8.89	6.68
Total Assets	1,067	1,010	597	526.76	408.62
Accounts Payable	24.36	25.1	17.8	14.45	10.15
Accrued Expenses	202.6	180.77	115.48	73.09	37.11
Current Portion of Leases	2.01	1.55	1.39	1.88	1.7
Current Income Taxes Payable	-	-	-	1.12	0.72
Current Unearned Revenue	0.58	-	-	7.76	33.11
Other Current Liabilities	17.14	4.76	4.36	2.54	0.05
Total Current Liabilities	246.7	212.18	139.02	100.84	82.84
Long-Term Debt	393.13	391.01	48.01	47.81	50.41
Long-Term Leases	41.56	40.16	35.61	31.76	34.33
Long-Term Unearned Revenue	4.86	5.43	5.52	5.24	8.68
Other Long-Term Liabilities	-	-	-	2.22	0.08
Total Liabilities	686.24	648.79	228.16	187.86	176.33
Common Stock	0.14	0.14	0.13	0.13	0.12
Additional Paid-In Capital	1,240	1,190	1,150	1,083	287.38
Retained Earnings	-831.28	-795.76	-744.67	-689.39	-651.83
Comprehensive Income & Other	-28.08	-33.76	-36.26	-54.67	596.62
Shareholders' Equity	381.03	360.72	368.84	338.9	232.28
Total Liabilities & Equity	1,067	1,010	597	526.76	408.62
Total Debt	436.69	432.72	85.01	81.45	86.44
Net Cash (Debt)	427.47	387.65	357.62	321.02	235.67
Net Cash Growth	10.27%	8.40%	11.40%	36.22%	162.22%
Net Cash Per Share	8.49	7.75	7.31	7.02	5.55
Filing Date Shares Outstanding	50.7	50.07	49.82	48.12	43.86
Total Common Shares Outstanding	50.69	50.06	49.73	48.09	43.86
Working Capital	750.05	717.68	389.8	373.14	272.91
Book Value Per Share	7.52	7.20	7.42	7.05	5.30
Tangible Book Value	381.03	360.72	368.84	338.9	232.28
Tangible Book Value Per Share	7.52	7.20	7.42	7.05	5.30
Machinery	48.71	43.92	41.46	33.98	36.29
Construction In Progress	1.13	0.48	0.05	0.43	0.02
Leasehold Improvements	22.42	21.02	20.02	19.1	21.18

Updated Feb 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q